Cytokines in Alzheimer's disease

Prog Neuropsychopharmacol Biol Psychiatry. 1991;15(4):481-95. doi: 10.1016/0278-5846(91)90023-t.

Abstract

1. Human astrocytoma cells produced biologically active interleukin-6 when treated with a variety of agents including bacterial lipopolysaccharides, viruses, and interleukin-1. 2. Both human recombinant IL-6 and IL-6 produced by stimulated astrocytes promoted differentiation of cultured neuronal cells and reduced survival time in culture. 3. Interleukin-6 and interleukin-1 stimulated the synthesis of the Alzheimer's disease beta-amyloid precursor protein. 4. Cytokines may be involved in stimulation of dystrophic neuritic sprouting, neuronal death, and amyloid deposition noted in the brains of Alzheimer's disease patients.

MeSH terms

  • Alzheimer Disease / metabolism*
  • Amyloid beta-Peptides / metabolism
  • Amyloid beta-Protein Precursor / biosynthesis
  • Animals
  • Astrocytoma / metabolism
  • Brain Neoplasms / metabolism
  • Cell Differentiation / drug effects
  • Cell Survival / drug effects
  • Cytokines / metabolism*
  • Cytokines / pharmacology
  • Endotoxins / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Interleukin-1 / pharmacology
  • Interleukin-6 / biosynthesis*
  • Interleukin-6 / pharmacology
  • Neurites / drug effects
  • Rats
  • Recombinant Proteins / pharmacology
  • Tumor Cells, Cultured

Substances

  • Amyloid beta-Peptides
  • Amyloid beta-Protein Precursor
  • Cytokines
  • Endotoxins
  • Interleukin-1
  • Interleukin-6
  • Recombinant Proteins